Showing 1,161 - 1,180 results of 24,337 for search '(( a step decrease ) OR ( 100 ((we decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 0.80s Refine Results
  1. 1161
  2. 1162
  3. 1163

    S1 Data - by Alhassan Abdul-Mumin (5986151)

    Published 2024
    “…The total number of deliveries and fresh stillbirths showed a step change with a marked decrease during the pandemic, while the macerated stillbirths showed a pulse change, a temporary marked decrease with a quick recovery over time.…”
  4. 1164
  5. 1165
  6. 1166

    Superiority of ARMA model identification during stochastic pacing vs. a time domain analysis after a step change in BCL. by Mathieu Lemay (330649)

    Published 2013
    “…<p><i>A</i>: Response of the Ca<sup>2+</sup>-driven model with positive Ca<sup>2+</sup> to APD coupling to a step decrease of BCL from 400 to 390 ms. …”
  7. 1167
  8. 1168
  9. 1169
  10. 1170
  11. 1171
  12. 1172
  13. 1173
  14. 1174
  15. 1175

    Light-emitting diode generated red light (LED-RL) at a fluence of 480 J/cm<sup>2</sup> significantly decreased relative fibroblast migration speed to 83.0±5.6% (p = 0.0393) compared to matched controls (100±5.8%). by Andrew Mamalis (5665591)

    Published 2015
    “…Light-emitting diode generated red light (LED-RL) at a fluence of 640 J/cm<sup>2</sup> significantly decreased relative fibroblast migration speed to 74.4±5.5% (p = 0.0003) compared to matched controls (100±4.2%). …”
  16. 1176

    Image1_Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism.TIF by Franciel Batista Felix (10699536)

    Published 2021
    “…BCA treatment shortened Ri from ∼23 h observed in vehicle-treated mice to ∼5.5 h, associated with an increase in apoptotic events and efferocytosis, both key steps for the resolution of inflammation. These effects of BCA were prevented by H89, an inhibitor of protein kinase A (PKA) and G15, a selective G protein–coupled receptor 30 (GPR30) antagonist. …”
  17. 1177

    Image2_Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism.TIF by Franciel Batista Felix (10699536)

    Published 2021
    “…BCA treatment shortened Ri from ∼23 h observed in vehicle-treated mice to ∼5.5 h, associated with an increase in apoptotic events and efferocytosis, both key steps for the resolution of inflammation. These effects of BCA were prevented by H89, an inhibitor of protein kinase A (PKA) and G15, a selective G protein–coupled receptor 30 (GPR30) antagonist. …”
  18. 1178

    Image4_Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism.TIF by Franciel Batista Felix (10699536)

    Published 2021
    “…BCA treatment shortened Ri from ∼23 h observed in vehicle-treated mice to ∼5.5 h, associated with an increase in apoptotic events and efferocytosis, both key steps for the resolution of inflammation. These effects of BCA were prevented by H89, an inhibitor of protein kinase A (PKA) and G15, a selective G protein–coupled receptor 30 (GPR30) antagonist. …”
  19. 1179

    Image3_Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism.TIF by Franciel Batista Felix (10699536)

    Published 2021
    “…BCA treatment shortened Ri from ∼23 h observed in vehicle-treated mice to ∼5.5 h, associated with an increase in apoptotic events and efferocytosis, both key steps for the resolution of inflammation. These effects of BCA were prevented by H89, an inhibitor of protein kinase A (PKA) and G15, a selective G protein–coupled receptor 30 (GPR30) antagonist. …”
  20. 1180

    Image3_Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism.TIF by Franciel Batista Felix (10699536)

    Published 2021
    “…BCA treatment shortened Ri from ∼23 h observed in vehicle-treated mice to ∼5.5 h, associated with an increase in apoptotic events and efferocytosis, both key steps for the resolution of inflammation. These effects of BCA were prevented by H89, an inhibitor of protein kinase A (PKA) and G15, a selective G protein–coupled receptor 30 (GPR30) antagonist. …”